PSAP and early-onset autosomal dominant Alzheimer disease: This leads to increased PGRN levels outside of the cell.27 PGRN has also been linked to certain neurodegenerative conditions, including Alzheimer’s disease and frontotemporal dementia.28,29 In the current study, the p.N215D mutation did not alter the lysosomal localization of PSAP.